ALPINE, UTAH, Sept. 16 /PRNewswire-FirstCall/ - Clifton Mining Company (OTC: CFTN) is pleased to announce that American Biotech Labs, a company in which Clifton owns approximately 30% has just finished its first set of tests using the ASAP Solution(R) against the MRSA (Methicillin-resistant Staphylococcus aureus) bacteria as well as Candida albicans yeast and the Trichomonas vaginalis bacteria.
Staphylococcus aureus can cause serious blood poisoning when it enters a wound. It was once easily treated with penicillin, but it has now mutated to the point where it is totally resistant to it. The next defense on the antibiotic ladder has been methicillin, but the strains of the bug that are resistant to methicillin have become increasingly common, especially in hospitals. They are known as MRSA (Methicillin-resistant Staphylococcus aureus) - dubbed the superbug. People who contract the MRSA superbug infections in hospitals can die in a matter of days.
In the test work, the 10 ppm ASAP Solution(R) was tested against six million colony forming units of the MSRA (per mL). The ASAP Solution(R) was able to kill 91.6% of the deadly bacteria in just 10 minutes, 98.8% in 30 minutes and 99.5% in an hour. Said Keith Moeller, VP of American Biotech Labs, "These results are very important because just 10 of these deadly bacteria per milliliter in your bloodstream could kill an adult human. The ASAP Solution(R) has been proven effective in killing hundreds of thousands of times that level of bacteria. Another important factor is that the ASAP Solution(R) can be used in, around, and on people where other toxic disinfectants cannot." The ASAP Solution(R) has already been government approved as a surface disinfectant for commercial, industrial, and residential use. Said Moeller, "We are doing some additional testing to meet EPA guidelines and we anticipate having hospital disinfectant approval in the next few months."
The product was also tested against Candida albicans yeast and the Trichomonas vaginalis bacteria. Said Moeller, "Both of these organisms are very problematic and can cause numerous difficulties including vaginal infections, diaper rash, thrush etc. We believe that in the near future we may be able to eliminate a great deal of suffering for women and children with our product. In the in vitro testing we were able to get close to a 100% kill on both organisms in just 10 minutes. We already have a patent pending on a feminine hygiene product."
American Biotech Labs was recently chosen by the United States Senate Committee for Homeland Defense as one of a few companies "that can and does make important contributions to homeland security." American Biotech Labs is officially listed in the Senate Registry as a company that can supply products for homeland defense. The registry lists the ASAP Solution(TM) as a product that is "proven to kill bacteria such as Staph, Tuberculosis, E-coli, Salmonella, a number of yeasts and even the Anthrax spore."
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance. These include economic, competitive, governmental, technological and other factors discussed in the company's business plan and due-diligence information.
SOURCE Clifton Mining Company
CO: Clifton Mining Company
ST: Utah
SU:
prnewswire.com
09/16/2002 07:00 EDT |
